Recurrent pulmonary exacerbations are associated with low fat free mass and low bone mineral density in young adults with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 13, Issue 3, 2014, Pages 328-334

  Alicandro, Gianfranco ^a   Bisogno, Arianna ^a   Battezzati, Alberto ^a   Bianchi, Maria Luisa ^b   Corti, Fabiola ^a   Colombo, Carla ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Body composition; Cystic fibrosis; DXA; Pulmonary exacerbations

Indexed keywords

ACUTE PULMONARY EXACERBATION; ADULT; ARTICLE; BODY COMPOSITION; BONE DENSITY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FAT FREE MASS; FEMALE; HUMAN; LUNG DISEASE; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; YOUNG ADULT; ADIPOSE TISSUE; ADOLESCENT; BODY MASS; COMPLICATION; LUNG FUNCTION TEST; METABOLISM; NUTRITIONAL ASSESSMENT; PHOTON ABSORPTIOMETRY; PNEUMONIA; RECURRENT DISEASE; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ABSORPTIOMETRY, PHOTON; ADIPOSE TISSUE; ADOLESCENT; ADULT; BODY COMPOSITION; BODY MASS INDEX; BONE DENSITY; CYSTIC FIBROSIS; FEMALE; HUMANS; MALE; NUTRITION ASSESSMENT; PNEUMONIA; RECURRENCE; RESPIRATORY FUNCTION TESTS; RETROSPECTIVE STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 84897113886     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2013.11.001     Document Type: Article

References (30)

1. Stallings V.A., Stark L.J., Robinson K.A., Feranchak A.P., Quinton H. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc 2008, 108:832-839. Clinical Practice Guidelines on Growth and Nutrition Subcommittee; Ad Hoc Working Group.
2. Gallagher D., Visser M., Sepúlveda D., Pierson R.N., Harris T., Heymsfield S.B. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups?. Am J Epidemiol 1996, 143:228-239.
3. Probst M., Goris M., Vandereycken W., Van Coppenolle H. Body composition in female anorexia nervosa patients. Br J Nutr 1996, 76:639-647.
4. Ionescu A.A., Evans W.D., Pettit R.J., Nixon L.S., Stone M.D., Shale D.J. Hidden depletion of fat-free mass and bone mineral density in adults with cystic fibrosis. Chest 2003, 124:2220-2228.
5. King S.J., Nyulasi I.B., Strauss B.J., Kotsimbos T., Bailey M., Wilson J.W. Fat-free mass depletion in cystic fibrosis: associated with lung disease severity but poorly detected by body mass index. Nutrition 2010, 26:753-759.
6. Hart N., Tounian A., Clement A., Boule M., Polkey Lofanso F. Nutritional status is an important predictor of diaphragm strength in young patients with cystic fibrosis. Am J Clin Nutr 2004, 80:1201-1206.
7. Ionescu A.A., Nixon L.S., Luzio S., Lewis-Jenkins V., Evans W.D., Stone M.D., et al. Pulmonary function, body composition, and protein metabolism in adults with cystic fibrosis. Am J Respir Crit Care Med 2001, 165:495-500.
8. Enright S., Chatham K., Ionescu A.A., Unnithan V.B., Shale D.J. The influence of body composition on respiratory muscle, lung function and diaphragm thickness in adults with cystic fibrosis. J Cyst Fibros 2007, 6:384-390.
9. Bilton D., Canny G., Conway S., Dumcius S., Hjelte L., Proesmans M., et al. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros 2011, 10(Suppl. 2):S79-S81.
10. Coin A., Sergi G., Minicuci N., et al. Fat-free mass and fat mass reference values by dual-energy X-ray absorptiometry (DEXA) in a 20-80year-old Italian population. Clin Nutr 2008, 27:87-94.
11. Lee T.W.R., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa in cystic fibrosis patients. J Cyst Fibros 2003, 2:29-34.
12. Wilkes D.L., Miller M.R., Hankinson J., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26:319-338.
13. Maselli J.H., Sontag M.K., Norris J.M., MacKenzie T., Wagener J.S., Accurso F.J. Risk factors for initial acquisition of Pseudomonas aeruginosa in children with cystic fibrosis identified by newborn screening. Pediatr Pulmonol 2003, 35:257-262.
14. Lai H.C., Kosorok M.R., Laxova A., Makholm L.M., Farrell P.M. Delayed diagnosis of US females with cystic fibrosis. Am J Epidemiol 2002, 156:165-173.
15. Selvadurai H.C., Blimkie C.J., Cooper P.J., Mellis C.M., Van Asperen P.P. Gender differences in habitual activity in children with cystic fibrosis. Arch Dis Child 2004, 89:928-933.
16. Bolton C.E., Ionescu A.A., Evans W.D., Pettit R.J., Shale D.J. Altered tissue distribution in adults with cystic fibrosis. Thorax 2003, 58:885-889.
17. Grossberg A.J., Scarlett J.M., Marks D.L. Hypothalamic mechanisms in cachexia. Physiol Behav 2010, 100:478-489.
18. Colombo C., Faelli N., Tirelli A.S., Fortunato F., Biffi A., Claut L. Analysis of inflammatory and immune response biomarkers in sputum and exhaled breath condensate by a multi-parametric biochip array in cystic fibrosis. Int J Immunopathol Pharmacol 2011, 24:423-432.
19. Ionescu A.A., Nixon L.S., Shale D.J. Cellular proteolysis and systemic inflammation during exacerbation in cystic fibrosis. J Cyst Fibros 2004, 3:253-258.
20. Heymsfield S., Lohman T., Wang Z., Going S., et al. Human body composition 2005, Human Kinetics Pub Inc. 2nd ed.
21. Gosker H.R., Engelen M.P., van Mameren H., van Dijk P.J., van der Vusse G.J., Wouters E.F., et al. Muscle fiber type IIX atrophy is involved in the loss of fat-free mass in chronic obstructive pulmonary disease. Am J Clin Nutr 2002, 76:113-119.
22. Vestbo J., Prescott E., Almdal T., Dahl M., Nordestgaard B.G., Andersen T., et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen City Heart Study. Am J Respir Crit Care Med 2006, 173:79-83.
23. Liou T.G., Adler F.R., Fitzsimmons S.C., Cahill B.C., Hibbs J.R., Marshall B.C. Predictive 5-year survivorship model of cystic fibrosis. Am J Epidemiol 2001, 153:345-352.
24. Buzzetti R., Alicandro G., Minicucci L., Notarnicola S., Furnari M.L., Giordano G., et al. Validation of a predictive survival model in Italian patients with cystic fibrosis. J Cyst Fibros 2012, 11:24-29.
25. Javier R.M., Jacquot J. Bone disease in cystic fibrosis: what's new?. Joint Bone Spine 2011, 78:445-450.
26. Bianchi M.L., Romano G., Saraifoger S., Costantini D., Limonta C., Colombo C. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 2006, 21:388-396.
27. Ionescu A.A., Nixon L.S., Evans W.D., Stone M.D., Lewis-Jenkins V., Chatham K., et al. Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 2000, 162:789-794.
28. Shead E.F., Haworth C.S., Barker H., Bilton D., Compston J.E. Osteoclast function, bone turnover and inflammatory cytokines during infective exacerbations of cystic fibrosis. J Cyst Fibros 2010, 9:93-98.
29. Williams J.E., Wells J.C., Wilson C.M., Haroun D., Lucas A., Fewtrell M.S. Evaluation of Lunar Prodigy dual-energy X-ray absorptiometry for assessing body composition in healthy persons and patients by comparison with the criterion 4-component model. Am J Clin Nutr 2006, 83:1047-1054.
30. Wong W.W., Hergenroeder A.C., Stuff J.E., Butte N.F., Smith E.O., Ellis K.J. Evaluating body fat in girls and female adolescents: advantages and disadvantages of dual-energy X-ray absorptiometry. Am J Clin Nutr 2002, 76:384-389.